Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - AbCellera Biologics (NASDAQ:ABCL), American Rebel Holdings (NASDAQ:AREB)
AbCellera BiologicsAbCellera Biologics(US:ABCL) Benzinga·2026-02-25 09:22

Core Insights - Axon reported fourth-quarter revenue of $796.72 million, surpassing analyst estimates of $755.40 million [1] - The company achieved fourth-quarter adjusted earnings of $2.15 per share, exceeding estimates of $1.60 per share [1] - Following the earnings report, Axon Enterprise shares increased by 16.2% to $514.21 in pre-market trading [1] Financial Performance - Fourth-quarter revenue: $796.72 million, beating estimates by $41.32 million [1] - Adjusted earnings per share: $2.15, exceeding estimates by $0.55 [1]